466 related items for PubMed ID: 19279317
1. Protective effects of a coumarin derivative in diabetic rats.
Bucolo C, Ward KW, Mazzon E, Cuzzocrea S, Drago F.
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
[Abstract] [Full Text] [Related]
2. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K, Yanagi Y, Tamaki Y, Usui T, Kubota N, Iriyama A, Terauchi Y, Kadowaki T, Araie M.
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[Abstract] [Full Text] [Related]
3. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrósio AF, Forrester JV.
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[Abstract] [Full Text] [Related]
4. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K, Jesmin S, Maeda S, Zaedi S, Shimojo N, Miyauchi T, Goto K.
Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
[Abstract] [Full Text] [Related]
5. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J, Zhou SX, Padillo E, Clarke KG, Gil DW.
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[Abstract] [Full Text] [Related]
6. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, Musashi K, Yoshimura N.
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[Abstract] [Full Text] [Related]
7. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
Kowluru RA, Menon B, Gierhart DL.
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1645-51. PubMed ID: 18385086
[Abstract] [Full Text] [Related]
8. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
Iliaki E, Poulaki V, Mitsiades N, Mitsiades CS, Miller JW, Gragoudas ES.
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
[Abstract] [Full Text] [Related]
9. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B, Sun JH, Xiang FF, Liu L, Li WJ.
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[Abstract] [Full Text] [Related]
10. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW.
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[Abstract] [Full Text] [Related]
11. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
Ma P, Luo Y, Zhu X, Ma H, Hu J, Tang S.
Biochem Biophys Res Commun; 2009 Mar 06; 380(2):402-6. PubMed ID: 19250642
[Abstract] [Full Text] [Related]
12. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
Shyong MP, Lee FL, Kuo PC, Wu AC, Cheng HC, Chen SL, Tung TH, Tsao YP.
Mol Vis; 2007 Jan 31; 13():133-41. PubMed ID: 17293777
[Abstract] [Full Text] [Related]
13. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Yang LP, Sun HL, Wu LM, Guo XJ, Dou HL, Tso MO, Zhao L, Li SM.
Invest Ophthalmol Vis Sci; 2009 May 31; 50(5):2319-27. PubMed ID: 19011009
[Abstract] [Full Text] [Related]
14. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH, Kim JH, Yu YS, Min BH, Kim KW.
Invest Ophthalmol Vis Sci; 2010 Mar 31; 51(3):1659-65. PubMed ID: 19875648
[Abstract] [Full Text] [Related]
15. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I, Hughes JM, Vogels IM, Schalkwijk CG, Van Noorden CJ, Schlingemann RO.
Exp Eye Res; 2009 Jun 15; 89(1):4-15. PubMed ID: 19284967
[Abstract] [Full Text] [Related]
16. Vascular endothelial growth factor in diabetes induced early retinal abnormalities.
Cukiernik M, Hileeto D, Evans T, Mukherjee S, Downey D, Chakrabarti S.
Diabetes Res Clin Pract; 2004 Sep 15; 65(3):197-208. PubMed ID: 15331199
[Abstract] [Full Text] [Related]
17. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ, Antonetti DA, Gardner TW.
Invest Ophthalmol Vis Sci; 2000 Oct 15; 41(11):3561-8. PubMed ID: 11006253
[Abstract] [Full Text] [Related]
18. Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats.
Bucolo C, Leggio GM, Drago F, Salomone S.
Biochem Pharmacol; 2012 Jul 01; 84(1):88-92. PubMed ID: 22484312
[Abstract] [Full Text] [Related]
19. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T, Matsubara A, Taniguchi K, Ogura Y.
Curr Eye Res; 2010 Feb 01; 35(2):146-54. PubMed ID: 20136425
[Abstract] [Full Text] [Related]
20. Effects of cloricromene, a coumarin derivative, on endotoxin-induced uveitis in Lewis rats.
Bucolo C, Cuzzocrea S, Mazzon E, Caputi AP.
Invest Ophthalmol Vis Sci; 2003 Mar 01; 44(3):1178-84. PubMed ID: 12601047
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
